Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J KEATING

Showing results (471-480 of 1,115) with videos related to

Pageof 112
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 16, 2022
The gut-brain axis: spatial relationship between spinal afferent nerves and 5-HT-containing enterochromaffin cells in mucosa of mouse colonKelsi N Dodds, Lee Travis, Melinda A Kyloh, et al.
Blood|November 19, 2011
Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemiaDeepa Sampath, Chaomei Liu, Karthik Vasan, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patientsV Fainstein, G P Bodey, L Elting, et al.
Leukemia & Lymphoma|September 1, 1993
Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabineF Di Raimondo, R Giustolisi, E Cacciola, et al.
Cancer|August 15, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopeniaPaolo Strati, William Wierda, Jan Burger, et al.
European Journal of Clinical Pharmacology|August 11, 1998
Psychomotor performance: investigating the dose-response relationship for caffeine and theophylline in elderly volunteersC A Bryant, A Farmer, B Tiplady, et al.
Blood|June 1, 1993
Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentM J Keating, S O'Brien, H Kantarjian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 9, 2015
Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cellsC Cameron Yin, Guilin Tang, Gary Lu, et al.
The British Journal of Nutrition|November 1, 1989
Dietary intakes and adipose tissue levels of linoleic acid in peptic ulcer diseaseJ Kearney, N P Kennedy, P W Keeling, et al.
Leukemia & Lymphoma|March 18, 2000
Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemiaM J Keating, T L Smith, S Lerner, et al.
Pageof 112

Showing results (471-480 of 1,115) with videos related to

Sort By:
Pageof 112
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 16, 2022
The gut-brain axis: spatial relationship between spinal afferent nerves and 5-HT-containing enterochromaffin cells in mucosa of mouse colonKelsi N Dodds, Lee Travis, Melinda A Kyloh, et al.
Blood|November 19, 2011
Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemiaDeepa Sampath, Chaomei Liu, Karthik Vasan, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patientsV Fainstein, G P Bodey, L Elting, et al.
Leukemia & Lymphoma|September 1, 1993
Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabineF Di Raimondo, R Giustolisi, E Cacciola, et al.
Cancer|August 15, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopeniaPaolo Strati, William Wierda, Jan Burger, et al.
European Journal of Clinical Pharmacology|August 11, 1998
Psychomotor performance: investigating the dose-response relationship for caffeine and theophylline in elderly volunteersC A Bryant, A Farmer, B Tiplady, et al.
Blood|June 1, 1993
Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentM J Keating, S O'Brien, H Kantarjian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 9, 2015
Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cellsC Cameron Yin, Guilin Tang, Gary Lu, et al.
The British Journal of Nutrition|November 1, 1989
Dietary intakes and adipose tissue levels of linoleic acid in peptic ulcer diseaseJ Kearney, N P Kennedy, P W Keeling, et al.
Leukemia & Lymphoma|March 18, 2000
Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemiaM J Keating, T L Smith, S Lerner, et al.
Pageof 112